Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TAK-188 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on TAK-188, a putative antibody-drug conjugate (ADC) targeting CCR8 (Oct 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TAK-188 | TAK188|TAK 188 | CCR8 Antibody 13 | Limited information is currently available on TAK-188, a putative antibody-drug conjugate (ADC) targeting CCR8 (Oct 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07205718 | Phase Ib/II | TAK-188 | A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors | Recruiting | USA | 0 |